< + > Kettering Health faces a ransomware attack and confirms a scam targeting its patients

After canceling some services due to a system-wide cybersecurity incident, Ohio-based Kettering Health said persons claiming to be team members are trying to scam patients by phone and has halted certain billing activities.

< + > Basil Systems Raises $11.5 Million to Help Life Sciences Companies Make Smarter, Faster Decisions with AI-Driven Intelligence

With 600M+ Indexed Records and Customers like Johnson & Johnson, Medtronic, and Baxter, Basil Helps Pharma and Medtech Companies Make Faster, Smarter Decisions Across Product and Regulatory Lifecycles; Basil Systems Transforms Fragmented Regulatory, Post-Market, and Clinical Data into Real-Time, Decision-Ready Insight

Basil Systems, the leading AI-powered product lifecycle intelligence platform for the life sciences industry, announced today it has raised a total of $11.5 million in funding led by Golden Ventures, with participation from Hearst Ventures and Argosy Capital, to expand its enterprise BasilIntel SaaS platform, deepen product capabilities, and accelerate the deployment of data-driven insights across the pharma and medical device industry.

The new funding will enable Basil to expand its data coverage, onboard additional enterprise clients, and expand the rollout of AI and machine learning to automate high-stakes, high-complexity workflows. The company plans to broaden its support to adjacent players across the life sciences ecosystem, including drug and device manufacturers, suppliers, clinical research organizations, and regulatory agencies.

Life sciences companies face complex, mission-critical operations that are still burdened by manual workflows, siloed data, and outdated tools. From regulatory submissions and clinical planning to post-market surveillance and competitive analysis, critical decisions are often made without clear, timely insight. Basil Systems changes that by delivering real-time, AI-powered intelligence that helps teams move faster, collaborate, reduce risk, and make smarter decisions across product development, regulatory strategy, and market execution.

Basil has built the largest indexed dataset in life sciences, BasilLink, with over 600 million records continuously updated, structured, and growing. This includes regulatory submissions, global drug labels, clinical trials, adverse event reports, guidances, regulations, recalls, citations, inspections, and more.

Its proprietary platform delivers answers to complex questions in seconds, such as identifying which materials are most often linked to knee implant failures or comparing label changes across oncology therapies in specific patient populations. These insights are accessible through a full-text natural language interface, with API connectivity and enterprise-grade infrastructure designed to support millions of concurrent users.

“Basil Systems is transforming how life sciences companies access and act on regulatory intelligence,” said Bert Amato, Venture Partner, Golden Ventures and Board Director. “What once took teams weeks or months of manual effort using disconnected systems, Basil now delivers in real time by providing actionable insights that drive better product decisions, mitigate risk, and accelerate approvals. This isn’t just a workflow improvement, it’s a fundamental shift in how healthcare innovation gets to market.”

“Basil Systems has built the most comprehensive, structured dataset in life sciences, with over 600 million records spanning regulatory filings, clinical trials, post-market events, drug labels, and more,” said Anthony Cirurgiao, Founder and CEO at Basil Systems. “Our AI-powered platform transforms that data into real-time answers for the strategic questions that drive product success. We’re not just accelerating workflows and decision making, but creating a new standard for how life sciences companies make critical decisions across innovation, regulatory, safety, and commercialization.”

The BasilIntel platform is already used by four of the five largest global medical device companies and is in active trials with three of the top global pharmaceutical firms.

Life sciences companies often struggle with fragmented, siloed data spread across departments and formats, which slows down critical regulatory and product decisions. While many solutions promise to fix this, they’re often too complex or unreliable. Basil Systems takes a streamlined, proven approach by using proprietary machine learning algorithms to automatically ingest and unify scattered data into a single, fully indexed source of truth. The result is faster access to insights, leaner operations, and a scalable foundation for AI-driven decision-making across the enterprise.

“Basil has built a centralized intelligence engine for how medical products are developed, approved, and perform in-market,” said Mohamed Shariff, Director Regulatory Affairs at J&J. “With unmatched depth in regulatory and real-world life sciences data, Basil gives companies the visibility and analytics they need to make faster, smarter decisions. It’s becoming the default infrastructure layer for data-driven strategy in life sciences.”

In addition to core regulatory and clinical insights, Basil’s platform is used for strategic product development, supply chain optimization, risk mitigation, and real-world evidence (RWE) analysis. It supports use cases across regulatory, clinical, quality, medical affairs, and commercial divisions to provide a unified system of record and intelligence.

About Basil Systems

Basil Systems delivers an AI-powered SaaS platform transforming how pharma and MedTech companies manage regulatory, clinical, and product lifecycle strategy. By structuring the world’s largest indexed database of regulatory, drug, device, and post-market data, Basil helps life sciences organizations accelerate development, reduce risk, and improve product performance. Trusted by industry leaders, Basil turns complex data into actionable insights that drive better decisions and better patient outcomes. Learn more at basilsystems.com and follow us on LinkedIn.

Originally announced April 29th, 2025

< + > This Week’s Health IT Jobs – May 21, 2025

It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of great health IT jobs for you! We hope you enjoy this look at some of the health IT jobs we saw healthcare organizations trying to fill this week.

Here’s a quick look at some of the health IT jobs we found:

• Health Service Administrator (HSA/RN) – NaphCare, Inc.
• Patient Safety Analyst – Saint Luke’s Health System
• Healthcare Operations Lead (Contract – Hire) – OpTech
• EHR Analyst – Kaleida Health
• Senior Analyst, Health Care Quality Management – CVS Health
• Medical/Health Care Program Analyst – State of Florida
• Specialist, Clinical Informatics – CVS Health
• Privacy Officer – Risk Management – ECU Health
• Health Systems Director – Alzheimer’s Association
• Clinical Concierge Medical Assistant – MultiCare Health System
• Public Benefit Specialist – Ensemble Health Partners
• Healthcare Compliance Consultant Sr. – Baylor Scott & White Health
• Privacy Specialist (Hybrid) – Blue Cross Blue Shield of Arizona
• Area Manager, Health Information Management – MRO
• Senior Payer Informatics Analyst – SCA Health
• Medical Records Specialist (Hybrid) – EyeCare Partners
• Health Info Technician – MultiCare Health System
• Systems Analyst-Patient Engagement – St. Luke’s Health System
• Medical Billing Specialist – Reproductive Partners Fertility Clinic- San Diego
• Patient Experience Representative – MultiCare Health System

If none of these jobs fit your needs, be sure to check out our previous health IT job listings.

Do you have an open health IT position that you are looking to fill? Contact us here with a link to the open position and we’ll be happy to feature it in next week’s article at no charge!

*Note: These jobs are listed by Healthcare IT Today as a free service to the community. Healthcare IT Today does not endorse or vouch for the company or the job posting. We encourage anyone applying to these jobs to do their own due diligence.

< + > The government should invest now in healthcare cybersecurity, says HSCC

Financially-constrained hospitals and health systems need federal funding and support to augment their cybersecurity workforces, according to a Health Sector Coordinating Council report to HHS.

< + > Reveleer Acquires Novillus to Expand Its AI-Powered Clinical Intelligence and Quality Solutions

Acquisition Strengthens Provider Engagement, Care Gap Management, and Compliance Solutions to Improve Health Outcomes and Financial Performance

Reveleer, the leading value-based care technology platform, today announced the acquisition of Novillus, a provider of insight-driven care gap management and frictionless provider engagement solutions. This acquisition further augments Reveleer’s comprehensive clinical intelligence and quality improvement solutions in value-based care, empowering health plans and providers to collaborate more effectively to improve patient outcomes, strengthen regulatory compliance, and bolster financial performance.

As the importance of Medicare Advantage Star Rating intensifies, and the healthcare industry increasingly emphasizes stronger alignment between payers and providers to succeed in value-based care, the acquisition positions Reveleer to further empower its customers to adapt and excel in a shifting value-based care environment. Novillus’ technology will accelerate Reveleer’s strategy of delivering modern, easy-to-use solutions that enable seamless collaboration between payers and providers for risk adjustment, quality improvement, and other patient improvement efforts. This includes the ability to pinpoint care gaps and performance trends at the provider group level to improve their education.

“By acquiring Novillus, we’re accelerating our strategy of aligning payers and providers to improve health outcomes through faster care gap closure,” said Jay Ackerman, CEO at Reveleer. “This acquisition strengthens our platform’s ability to deliver unmatched AI-powered quality and clinical intelligence solutions, while helping our customers not only meet, but exceed their goals for Star Rating performance, risk adjustment accuracy, and care gap closure. All are key areas that drive improved patient outcomes, reduce the cost of care, and improve financial success.”

Novillus’ technologies will extend Reveleer’s unique ability to bring payers and providers together through enhanced AI automation, real-time roster management, and advanced provider engagement workflows. Its Clean Provider Data solution strengthens regulatory compliance by supporting consistent adherence to the federal No Surprises Act and other regulations, reducing risk, improving directory accuracy, enhancing patient satisfaction, and minimizing provider abrasion.

The acquisition will deliver immediate value for both Reveleer and Novillus customers: health plans gain access to expanded, year-round patient improvement capabilities, while Novillus users can leverage a broader suite of value-based care solutions, enhanced resources, and AI-powered innovations to scale their impact.

“Our shared vision is to revolutionize how health plans and providers use data to drive better outcomes,” said Jerry Hagan, CEO at Novillus. “By joining Reveleer, we can accelerate our mission to improve provider engagement, close care gaps, and maximize regulatory compliance at scale. This is a win for our customers, their patients, and the broader value-based care ecosystem.”

The combined company will serve 72 million covered lives and work with 86 leading healthcare organizations across the U.S., further establishing Reveleer as the go-to solution for health plans and providers navigating the complexities of value-based care.

“Over the past three years, Reveleer has taken a strategic approach to broadening its offerings and building out one of the most comprehensive value-based care platforms on the market,” said Andrew Adams, Co-Founder and Managing Partner at Oak HC/FT. “With the acquisition of Novillus, Reveleer’s expanded offerings in care gap closure and provider data stand to deliver even more value to health plans, providers, and patients.”

To learn more, visit reveleer.com.

About Reveleer

As the industry’s pioneering value-based care (VBC) technology platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by providers and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI-powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at reveleer.com.

About Novillus

Novillus was founded in 2015 on the belief that it should be easier for health plans to collaborate with their provider group partners to drive improved outcomes for patients and improve health plan performance. The Company solves complex payer and provider group workflow and collaboration challenges with digital solutions and omni-channel engagement expertise. Novillus’s comprehensive approach improves outcomes for all lines of business, including Medicare and associated Star Rating, Medicaid, ACA, with full support for quality and risk adjustment gaps and an integrated display of incentives.

Originally announced April 22nd, 2025

< + > Brellium Raises $16.7 Million to Build Healthcare’s AI-Powered Clinical Compliance Platform

A few years before co-founding Brellium, I had a medical misdiagnosis that snowballed into two years of frustration—shuffling from specialist to specialist, trying treatment after treatment, just to end up with a stack of bills and an endless game of phone tag with insurance. Later, I found out that all of it could’ve been avoided if a couple of boxes had been checked in my chart. I was shocked; something as simple as a documentation oversight had a profound domino effect on the quality of care I received.

That experience made one thing painfully clear: the system wasn’t just failing me, it was also failing providers, who lacked the necessary tools to deliver quality care. That’s why we started Brellium: to improve the standard of care in the US healthcare system by empowering providers to treat their patients with measurement-based, clinically accurate, and compliant care that helps people get healthier, faster.

Chart Reviews are Crucial, but Costly

When you receive medical care, your provider documents your visit according to clinical and payor requirements. This documentation ensures that insurance covers the services provided and that you receive the correct care.

Failing to meet these requirements has serious consequences for provider groups. If payor requirements aren’t met, clinics risk prepayment reviews, insurance clawbacks, and financial instability. (Imagine having to pay back funds that have already been spent on salaries, operations, and keeping your business afloat.) On the clinical side, documentation gaps can lead to misdiagnoses, inadequate treatment, and poor patient outcomes.

Manual Chart Reviews: a Lose-Lose Scenario

Despite the high stakes, most clinics don’t have the bandwidth to audit every patient visit. Instead, they manually spot-check a small percentage, hoping to catch critical errors before they become costly problems. But manual reviews are labor-intensive, prone to errors, and fail to scale with growing patient volumes. This forces clinics to choose between compliance and efficiency—a lose-lose scenario.

To make matters worse, payor requirements are notoriously unclear. A recent audit of Medicaid-funded ABA therapy in Indiana, for example, found that every sampled month contained improper or potentially improper payments, primarily due to inadequate documentation. The frustrating reality for many provider groups is that documentation requirements are opaque, leaving clinics to navigate compliance without enough guidance or support.

Clinics need a way to ensure compliance without drowning in administrative work, and the healthcare system needs a smarter, more scalable approach to quality assurance.

Brellium is the AI-Powered Clinical Compliance Platform

Clinical teams use Brellium to ensure every patient visit meets payor & clinical quality standards – without the manual workload. Instead of reactive spot-checks, Brellium proactively audits every patient visit, identifying compliance risks before they become problems. Providers then receive instant notifications when charts need corrections, complete with clear instructions on how to fix them.

In the unlikely event a payor claws back reimbursement on a Brellium-approved chart, we’ll foot the bill.

With Brellium, providers can instantly detect and correct critical issues, such as:

• Copy-pasted provider notes from previous sessions

• Contraindicated prescription medications

• Session length discrepancies with what was billed to insurance

• Flagging decreases in patient condition over time

• And hundreds more

Leading healthcare organizations like Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, Talkiatry, and more trust Brellium to streamline compliance across millions of patient visits. We’ve audited millions of charts, equipping organizations with deep insight into payor expectations and documentation standards.

The results already speak for themselves. Rula is leveraging clinical note data to improve quality of care; Lightfully Behavioral Health reduced time spent on chart auditing by 87%; DoubleCare ABA cut QA costs by over 80%. By eliminating inefficiencies and reducing administrative burden, Brellium helps clinics prioritize patient care while ensuring compliance with confidence.

Improving the Standard of Care in the U.S. Healthcare System

Over the past few years, Brellium has grown from an ambitious idea to a bona fide solution, thanks to an incredible team of engineers, investors, and customers who believe in our mission.

We’ve raised $16.7 million in Series A funding from First Round Capital, Left Lane Capital, Menlo Ventures, Digital Health Venture Partners, Kearny Jackson, and Necessary Ventures alongside a group of world-class angel investors, including Andrew Adams (CEO at Headway), Steve Gutentag and Demitri Karagas (Co-Founders of Thirty Madison), Cory Levy (Z Fellows), and Fiat Ventures. Their support has allowed us to grow our team, accelerate our product roadmap, and take meaningful steps toward revolutionizing clinical compliance.

Our mission is simple, but bold: to improve the standard of care in the U.S. healthcare system. Healthcare compliance shouldn’t be a black box. We’re building a network where providers can learn from each other, avoid common mistakes, and ultimately improve patient care. By aligning payors and providers under a single, transparent framework, we can create a healthcare ecosystem that’s more efficient, compliant, and ultimately better for patients.

We’re hiring across numerous roles. If improving the quality of care in the US healthcare system is what you’d like to spend the next few years of your career building towards, we’d love to hear from you.

Originally announced April 17th, 2025

< + > How can telemedicine better serve the unique needs of women's behavioral health?

Dr. Sipra Laddha, a physician expert in women's health and virtual care, says telehealth and AI can work in tandem to help women – and all patients – who need mental healthcare, even in a time of limited access.